跳至主要内容
临床试验/CTRI/2024/12/078246
CTRI/2024/12/078246尚未招募不适用

A Descriptive Observational Study on Materiovigilance of Dental Materials in an Outpatient Department of Dentistry at Government Hospitals in Jaipur

未提供1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年12月27日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
试验地点
1
主要终点
Pattern of Adverse Events in percentages

研究概览

简要总结

Medical devices are extensively used for the diagnosis, prevention and treatment of different diseases. Even though their use is beneficial to the patients immensely but they also carry significant potential risks. Medical devices are classified into three classes. Dental materials are categorized as Class II medical devices associated with moderate risk according to USFDA.

Materiovigilance is the coordinated system of identification, collection, reporting, and analysis of any untoward occurences associated with the use of medical devices.

Materiovigilance in dentistry is relatively a new concept in India and still in an infancy stage and faces many challenges such as lack of awareness, under reporting, inadequate training and insufficient resources.

Therefore it is of utmost importance to promote and strengthen materiovigilance in Dentsitry, by creating a culture of reporting and encouraging research by generating evidence based data on the safety of medical devices.

Regarding this very few studies have been planned, so this evidence based research will enhance and give an insight into possible device induced Adverse Events with the objective to study and report the adverse events at patient’s first scheduled follow up visit within 3 months period following the use of prosthesis, appliances and materials used in dentistry in a sample size of 150 patients.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Patients visiting to treating Dental Surgeon on their first scheduled follow-up visit within 3 months period following the use of any Dental materials appliances and prosthesis More than 18 years of age of either sex Patient who give their consent to participate in the study.

排除标准

  • Immunocompromised Patients Patients having Diabetes Mellitus Pregnant & Lactating females Patients using immunomodulatory drugs and oral contraceptive pills.

结局指标

主要结局

Pattern of Adverse Events in percentages

时间窗: Within Three months time period

次要结局

  • Evaluation of the Knowledge, Attitude, Practice and Barriers of reporting Adverse Events(6 months)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr Jaya Sharma

SMS MEDICAL COLLEGE AND HOSPITAL

研究点 (1)

Loading locations...

相似试验

An Observational Study on Adverse Events following... | 临床试验